 |
AC |  |
| ISIN | FR0000120404 |
| Security | AC |
| Exchange | ICE Europe |
| Type | Future |
Futures
| Exp. date | Last | Open Interest | |
|---|---|---|---|
| 10/21 | |||
| 11/21 | |||
| 12/21 | |||
| 1/22 | |||
| 2/22 | |||
| 3/22 | |||
| 4/22 | |||
| 5/22 | |||
| 6/22 | |||
| 7/22 | |||
| 8/22 | |||
| 9/22 | |||
| 10/22 | |||
| 11/22 | |||
| 12/22 | |||
| 1/23 | |||
| 2/23 | |||
| 3/23 | |||
| 4/23 | |||
| 5/23 | |||
| 6/23 | |||
| 7/23 | |||
| 8/23 | |||
| 9/23 | |||
| 10/23 | |||
| 11/23 | |||
| 12/23 | |||
| 1/24 | |||
| 2/24 | |||
| 3/24 | |||
| 4/24 | |||
| 5/24 | |||
| 6/24 | |||
| 7/24 | |||
| 8/24 | |||
| 9/24 | |||
| 10/24 | |||
| 11/24 | |||
| 12/24 | |||
| 1/25 | |||
| 2/25 | |||
| 3/25 | |||
| 4/25 | |||
| 5/25 | |||
| 6/25 | |||
| 7/25 | |||
| 8/25 | |||
| 9/25 | |||
| 10/25 | |||
| 11/25 | |||
| 12/25 | |||
| 1/26 | |||
| 2/26 | |||
| 3/26 | |||
| 4/26 | |||
| 5/26 | |||
| 6/26 | |||
| 7/26 | |||
| 8/26 | |||
| 9/26 |
News
- AzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as Treatment for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-Associated Colitis
09/08/2021 / 14:30 - GlobeNewswire - Questex’s International Hospitality Investment Forum (IHIF) successfully reconnects global leaders in the hospitality investment and development sector – for the first time in over 18 months
09/04/2021 / 18:19 - GlobeNewswire - AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year
09/03/2021 / 13:52 - GlobeNewswire - AC Immune to Participate in Upcoming Virtual Investor Conferences in September
09/02/2021 / 13:00 - GlobeNewswire - AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease
08/31/2021 / 13:30 - GlobeNewswire
Real-time